• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
FinanceCrime

Why Martin Shkreli Is Guilty When Investors Didn’t Lose

By
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Bloomberg
Bloomberg
Down Arrow Button Icon
August 5, 2017, 2:05 PM ET
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, right, arrives at federal court with his attorney Benjamin Brafman in the Brooklyn borough of New York, U.S., on Monday, July 10, 2017. Shkreli's impromptu trial discussions with reporters at the Brooklyn federal courthouse are over as the judge overseeing the case ordered the former pharmaceutical executive to stop talking about it in and around the building. Photographer: Peter Foley/BloombergPeter Foley Bloomberg

Martin Shkreli became notorious for raising the price of a potentially life-saving HIV drug by 5,000 percent overnight and getting banned from Twitter for harassing a female journalist. His criminal fraud trial in Brooklyn, New York, had nothing to do with any of that, however. It was about whether laws were broken when the fund manager got in a hole and lied about it. He managed to make up the losses before getting caught, but that didn’t keep him from being convicted of fraud Aug. 4.

1. What were the charges?

He was accused of lying to investors about two, now-defunct, hedge funds that he managed, MSMB Capital and MSMB Healthcare. Prosecutors said he ran a Ponzi-like scheme, using investors’ money to start a drug company, Retrophin Inc., and later looting $11 million of Retrophin assets to pay them off.

2. What was he convicted of?

The jury found him guilty of two counts of securities fraud and one count of conspiracy to commit securities fraud, related to the operations of MSMB Healthcare fund. He was acquitted of fraud charges related to Retrophin, where prosecutors alleged the biggest losses occurred.

3. What were the lies that got him convicted?

Documents presented in court show that Shkreli lied about everything from the value of the funds he managed — he claimed it was $100 million, when at one point, the net asset value of a fund fell to minus 33 cents — to the performance of the funds, claiming they were outperforming the S&P 500 Index. He accepted investments until the last minute, before shutting the funds down. And he promised investors a full refund or shares in his startup pharmaceutical company.

4. How much did investors lose?

Nothing. Shkreli partly repaid them with Retrophin stock and several witnesses told the jury they ended up with multimillion-dollar profits. One invested $1.25 million in Shkreli’s hedge fund, got $1.6 million back and 150,000 Retrophin shares, currently worth about $2.9 million. Another said she ended up with a $2.7 million profit from a $300,000 initial investment. But they struggled, sometimes for years, to get the money back.

5. So if no one lost money, what’s the problem?

Think of it this way: In “Ferris Bueller’s Day Off,” Matthew Broderick’s character leaves his Ferrari with two parking valets. They take the car for a joyride and return it undamaged. No one was hurt. But they broke the law — the valets stole the car.

6. How did prosecutors convince the jury there was a crime?

By showing he lied to investors. It’s illegal to make material misstatements of fact to investors. According to the controlling laws enacted to protect investors, a “material fact” is anything that would be important in the decision-making process of a reasonable investor.

7. What was Shkreli’s defense?

His lawyers used a “no harm, no foul” argument focused on the fact that investors made money. During cross examination of investors, the defense argued that investors didn’t question Shkreli’s peculiar behavior because he was a biotech genius.

8. What’s he facing now?

He is almost certain to go to prison. Shkreli, 34, faces as long as 20 years behind bars, although he’s likely to serve much less. The judge let Shkreli return home, where he’s spent hours each day on social media. She said she’d see him soon, though she didn’t set a date for sentencing.

Martin Shkreli became notorious for raising the price of a potentially life-saving HIV drug by 5,000 percent overnight and getting banned from Twitter for harassing a female journalist. His criminal fraud trial in Brooklyn, New York, had nothing to do with any of that, however. It was about whether laws were broken when the fund manager got in a hole and lied about it. He managed to make up the losses before getting caught, but that didn’t keep him from being convicted of fraud Aug. 4.

About the Author
By Bloomberg
See full bioRight Arrow Button Icon

Latest in Finance

InvestingSports
Big 12 in advanced talks for deal with RedBird-backed fund
By Giles Turner and BloombergDecember 13, 2025
1 hour ago
Spanish Prime Minister Pedro Sánchez often praises the financial and social benefits that immigrants bring to the country.
EuropeSpain
In a continent cracking down on immigration and berated by Trump’s warnings of ‘civilizational erasure,’ Spain embraces migrants
By Suman Naishadham and The Associated PressDecember 13, 2025
3 hours ago
EconomyAgriculture
More financially distressed farmers are expected to lose their property soon as loan repayments and incomes continue to falter
By Jason MaDecember 13, 2025
4 hours ago
InvestingStock
There have been head fakes before, but this time may be different as the latest stock rotation out of AI is just getting started, analysts say
By Jason MaDecember 13, 2025
7 hours ago
Politicsdavid sacks
Can there be competency without conflict in Washington?
By Alyson ShontellDecember 13, 2025
7 hours ago
Investingspace
SpaceX sets $800 billion valuation, confirms 2026 IPO plans
By Loren Grush, Edward Ludlow and BloombergDecember 13, 2025
9 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
2 days ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
1 day ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.